🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Erin R. Rudzinski

University of Indianapolis

ORCID: 0000-0002-7591-956X

Also affiliated with Indiana University Indianapolis, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.276Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials

Cancer(2025)10.1002/cncr.35929
Top 57%
0.276DataRank
Top 57%5 citations

Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger +7 more

Papers

Driven by 18 papers — median percentile 43. Top paper: “Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group”.

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group

The Lancet Oncology(2024)10.1016/s1470-2045(24)00255-9
N/A
0.907DataRank · unranked
43 citations

Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden +10 more

Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials

Cancer(2025)10.1002/cncr.35929
Top 57%
0.276DataRank
Top 57%5 citations

Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger +7 more

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10560
N/A
0DataRank · unranked
2 citations

Kathleen Ludwig, Donald A. Barkauskas, Steven G. DuBois, Joan Ronan, Erin R. Rudzinski +10 more

Somatic activating BRAF variants cause isolated lymphatic malformations

medRxiv(2021)10.1101/2021.11.03.21265682
N/A
0DataRank · unranked
1 citations

Dana M. Jensen, Victoria Dmyterko, Giridhar M. Shivaram, Candace T. Myers, Cate Paschal +9 more

Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction

American Journal Of Pathology(2022)10.1016/j.ajpath.2022.03.011
N/A
0DataRank · unranked
34 citations

Shidan Wang, Erin R. Rudzinski, Saloni Agarwal, Ruichen Rong, Donald A. Barkauskas +7 more

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1663
N/A
0DataRank · unranked
28 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

European Journal of Cancer(2022)10.1016/j.ejca.2022.03.022
N/A
0DataRank · unranked
31 citations

Rajkumar Venkatramani, Anton Schönstein, Svetlana Pack, Rita Alaggio, Christian Vokuhl +13 more

Somatic activating BRAF variants cause isolated lymphatic malformations

Human Genetics and Genomics Advances(2022)10.1016/j.xhgg.2022.100101
N/A
0DataRank · unranked
21 citations

Dana M. Jensen, Victoria Dmyterko, Giridhar M. Shivaram, Candace T. Myers, Cate Paschal +9 more

ARST2031: A study to compare early use of vinorelbine and maintenance therapy for patients with high risk rhabdomyosarcoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps11591
N/A
0DataRank · unranked
5 citations

Leo Mascarenhas, Wei Xue, Sarah S. Donaldson, Dana L. Casey, John Shern +14 more

Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor Microenvironment

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1111
N/A
0DataRank · unranked
35 citations

April A. Apfelbaum, Erin R. Rudzinski, Xuemei Deng, Wei Jiang, Sudha Sud +11 more

Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas

Pediatric Blood & Cancer(2023)10.1002/pbc.30556
N/A
0DataRank · unranked
26 citations

Jacquelyn Crane, Josephine H. HaDuong, Erin R. Rudzinski, Suzanne L. Wolden, Roshni Dasgupta +4 more

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10008
N/A
0DataRank · unranked
5 citations

Kathleen Ludwig, David Hall, Donald A. Barkauskas, Stephan D. Voss, Steven G. DuBois +12 more

Data from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

(2023)10.1158/1078-0432.c.6532878.v1
N/A
0DataRank · unranked
0 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testing

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101886
N/A
0DataRank · unranked
7 citations

Jennifer N. Cech, Cate Paschal, Bri Dingmann, Anna I. Scott, Jenny Thies +24 more

Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials

Cancer(2024)10.1002/cncr.35457
N/A
0DataRank · unranked
4 citations

Jamie M. Aye, Jacquelyn Crane, Sapna Oberoi, Frank M. Balis, Smita Bhatia +18 more

Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group

Cancer(2020)10.1002/cncr.33275
N/A
0DataRank · unranked
45 citations

Yueh‐Yun Chi, Minjie Li, Suzanne L. Wolden, Dana L. Casey, Jonathan C. Routh +7 more

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group

Human Genetics and Genomics Advances(2025)10.1016/j.xhgg.2025.100466
N/A
0DataRank · unranked
0 citations

Christina L. Magyar, Bailey A. Martin‐Giacalone, Michael E. Scheurer, Deborah A. Marquez-Do, Mark Zobeck +17 more

Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group

Pediatric Blood & Cancer(2020)10.1002/pbc.28243
N/A
0DataRank · unranked
9 citations

Yueh‐Yun Chi, Jing Tian, Erin R. Rudzinski, Odion Binitie, Roshni Dasgupta +4 more